A recent comparison of patients with a post-COVID ME/CFS diagnosis versus patients with solely a long COVID diagnosis showed that both groups had lower ADRB2 levels than healthy controls [48]. Here, ADRB2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.